Ondřej Kubeček

510 total citations
31 papers, 339 citations indexed

About

Ondřej Kubeček is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ondřej Kubeček has authored 31 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Ondřej Kubeček's work include Cancer Immunotherapy and Biomarkers (8 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Melanoma and MAPK Pathways (5 papers). Ondřej Kubeček is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Melanoma and MAPK Pathways (5 papers). Ondřej Kubeček collaborates with scholars based in Czechia, Spain and Germany. Ondřej Kubeček's co-authors include Jindřich Kopecký, Stanislav Filip, Jiřı́ Petera, Jiří Špaček, Ján Laco, Peter Priester, Pavla Paterová, Veronika Vymetálková, Ľudmila Vodičková and Klára Červená and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Ondřej Kubeček

26 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ondřej Kubeček Czechia 8 171 101 70 62 60 31 339
L. Cannella Italy 9 143 0.8× 69 0.7× 55 0.8× 77 1.2× 70 1.2× 26 276
Pietro Del Medico Italy 9 207 1.2× 86 0.9× 171 2.4× 112 1.8× 61 1.0× 15 420
Jennifer McLachlan United Kingdom 10 113 0.7× 45 0.4× 116 1.7× 58 0.9× 74 1.2× 21 280
Domenico Priolo Italy 6 169 1.0× 59 0.6× 169 2.4× 97 1.6× 92 1.5× 9 364
Uwe-Jochen Göhring Germany 13 199 1.2× 105 1.0× 61 0.9× 51 0.8× 163 2.7× 35 531
Samreen Naz Pakistan 11 117 0.7× 45 0.4× 35 0.5× 103 1.7× 47 0.8× 16 298
Lindsey E. Minion United States 8 170 1.0× 50 0.5× 152 2.2× 58 0.9× 142 2.4× 15 438
Fernando Cotait Maluf Brazil 10 167 1.0× 139 1.4× 30 0.4× 97 1.6× 41 0.7× 41 375
Gaetano Saggio Italy 13 210 1.2× 70 0.7× 188 2.7× 86 1.4× 94 1.6× 28 468
Alberto Villanueva Spain 8 163 1.0× 38 0.4× 131 1.9× 67 1.1× 176 2.9× 12 419

Countries citing papers authored by Ondřej Kubeček

Since Specialization
Citations

This map shows the geographic impact of Ondřej Kubeček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ondřej Kubeček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ondřej Kubeček more than expected).

Fields of papers citing papers by Ondřej Kubeček

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ondřej Kubeček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ondřej Kubeček. The network helps show where Ondřej Kubeček may publish in the future.

Co-authorship network of co-authors of Ondřej Kubeček

This figure shows the co-authorship network connecting the top 25 collaborators of Ondřej Kubeček. A scholar is included among the top collaborators of Ondřej Kubeček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ondřej Kubeček. Ondřej Kubeček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambrożkiewicz, Filip, Viktor Hlaváč, Lenka Červenková, et al.. (2025). Genetic differences between primary colorectal cancer and its paired synchronous and metachronous metastases. International Journal of Cancer. 158(1). 120–130. 1 indexed citations
3.
Kubeček, Ondřej, Klára Červená, Jáchym Rosendorf, et al.. (2023). The dynamics of telomere length in primary and metastatic colorectal cancer lesions. Scientific Reports. 13(1). 9097–9097. 2 indexed citations
4.
Kubeček, Ondřej, Soňa Vodenková, Sandra García‐Mulero, et al.. (2023). Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer. Frontiers in Oncology. 13. 1133598–1133598. 6 indexed citations
5.
Červená, Klára, Ondřej Kubeček, Vendula Novosadová, et al.. (2023). Can Plasma miR-122-5p and miR-142-5p Predict Relapse in Metastatic Colorectal Cancer Patients?. 8(1). 1 indexed citations
6.
Kubeček, Ondřej, Ján Laco, Jiří Špaček, et al.. (2021). Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer. Current Oncology. 28(4). 2914–2927. 1 indexed citations
7.
Kubeček, Ondřej, et al.. (2021). Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors. Life. 11(12). 1387–1387. 20 indexed citations
8.
Kopecký, Jindřich, Ondřej Kubeček, Tomáš Büchler, et al.. (2021). Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors. In Vivo. 35(5). 2981–2990. 1 indexed citations
9.
Kopecký, Jindřich, et al.. (2021). Prognostic value of blood cell count-derived ratios in BRAF-mutated metastatic melanoma. Biomedical Papers. 166(4). 393–404. 3 indexed citations
10.
Filip, Stanislav, et al.. (2020). Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics. 12(10). 940–940. 2 indexed citations
11.
Filip, Stanislav, Veronika Vymetálková, Jiřı́ Petera, et al.. (2020). Distant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review. International Journal of Molecular Sciences. 21(15). 5255–5255. 54 indexed citations
12.
Kopecký, Jindřich & Ondřej Kubeček. (2020). How to manage side effects of immunotherapy. 14(Suppl.C). 6–12.
13.
Kubeček, Ondřej, Jiřina Martı́nková, Jaroslav Chládek, et al.. (2019). Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer. Cancer Chemotherapy and Pharmacology. 85(2). 353–365. 4 indexed citations
14.
Kopecký, Jindřich, et al.. (2019). Hepatic Injury Induced by a Single Dose of Nivolumab – a Case Report and Literature Review. Klinicka onkologie. 32(2). 133–138. 16 indexed citations
15.
Kubeček, Ondřej, et al.. (2017). Immunotherapy related toxicities. 11(2). 83–87. 1 indexed citations
16.
Kubeček, Ondřej, Ján Laco, Jiří Špaček, et al.. (2017). The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clinical & Experimental Metastasis. 34(5). 295–307. 103 indexed citations
17.
Kubeček, Ondřej & Jindřich Kopecký. (2016). Microsatellite instability in melanoma: a comprehensive review. Melanoma Research. 26(6). 545–550. 25 indexed citations
18.
Kubeček, Ondřej, et al.. (2016). Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report. BMC Cancer. 16(1). 684–684. 11 indexed citations
19.
Kubeček, Ondřej, et al.. (2016). Microsatellite instability as a predictive factor for immunotherapy in malignant melanoma. Medical Hypotheses. 93. 74–76. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026